Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933280

Cover Image

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933280

Ventricular Assist Device Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034

PUBLISHED:
PAGES: 156 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4850
Unprintable PDF & Excel (Multi User License)
USD 5850
PDF, Excel & PPT (Enterprise License)
USD 6850

Add to Cart

Growth Factors of ventricular assist device (VAD) Market

The global ventricular assist device (VAD) market is witnessing robust growth due to the rising prevalence of heart failure and increasing adoption of mechanical circulatory support systems worldwide. According to Fortune Business Insights, the global ventricular assist device market size was valued at USD 1.49 billion in 2025. The market is projected to grow from USD 1.65 billion in 2026 to USD 4.25 billion by 2034, registering a strong CAGR of 12.57% during the forecast period (2026-2034). North America dominated the global VAD market with a 50.18% market share in 2025, supported by advanced healthcare infrastructure and high adoption of innovative cardiac devices.

Market Overview

Ventricular assist devices are implantable mechanical pumps designed to support heart function and blood flow in patients suffering from severe heart failure. These devices assist the left, right, or both ventricles of the heart by pumping blood to the rest of the body. VADs are widely used as Bridge-to-Transplant (BTT), Destination Therapy (DT), Bridge-to-Candidacy (BTC), and Bridge-to-Recovery (BTR) solutions when heart transplantation is not immediately feasible.

The increasing global burden of heart failure is a major factor driving demand. As per the Journal of Cardiac Failure (2023), approximately 6.7 million Americans aged 20 and above were affected by heart failure, and this number is expected to reach 8.5 million by 2030, significantly boosting the need for ventricular assist devices.

Market Trends

Rapid technological advancements are transforming the VAD market. The integration of artificial intelligence (AI) and machine learning in cardiac care is improving patient risk assessment, surgical planning, and post-implantation monitoring. Advanced VADs such as HeartMate III and DuraHeart feature smaller sizes, lower rotational speeds, improved anatomic design, and reduced infection risks.

Fully implantable systems represent a key innovation trend. For instance, Medtronic's HVAD system, approved by the U.S. FDA, eliminates external driveline cables, reducing infection risks and improving patient mobility. Such advancements are expected to accelerate adoption across developed and emerging markets.

Market Growth Drivers

The rising prevalence of heart failure remains the most significant growth driver. Heart failure affects nearly 1-2% of the population in Western countries, and globally over 5.5 million individuals were affected in 2020. The growing geriatric population further increases disease prevalence, as elderly individuals are at higher risk of cardiovascular disorders.

Another major driver is the long waiting period for heart transplants. According to the Health Resources & Services Administration (2022), over 105,800 patients were on organ transplant waiting lists. Due to the shortage of donor hearts, VADs are increasingly used as long-term destination therapy and bridge-to-transplant solutions.

Additionally, market players are focusing on R&D initiatives and product expansion. For example, in June 2021, Abbott expanded the supply of its HeartMate 3 device to meet growing global demand.

Restraining Factors

Despite strong growth potential, the market faces challenges related to the high cost of VAD implantation. In the U.S., LVAD implantation procedures can cost between USD 175,000 and USD 200,000, limiting accessibility in cost-sensitive regions. Device-related complications such as pump failure, power supply issues, and infection risks further restrain adoption.

Segmentation Analysis

By product, the Left Ventricular Assist Device (LVAD) segment dominated the market, accounting for 87.10% share in 2026, driven by high implantation rates and FDA approvals.

By flow type, continuous flow devices held the largest share at 88.81% in 2026 due to durability, lower maintenance, and improved patient outcomes.

By application, Destination Therapy (DT) dominated with a 45.75% market share in 2026, while Bridge-to-Transplant is expected to grow at the fastest rate.

By end user, hospitals & ASCs led the market with 65.95% share in 2026, owing to a higher volume of surgical procedures.

Regional Insights

North America generated USD 0.75 billion in revenue in 2025 and continues to dominate due to advanced cardiac care systems and favorable reimbursement policies. Europe holds the second-largest share, driven by strong R&D investments. Asia Pacific is expected to witness the highest CAGR due to expanding healthcare infrastructure and supportive government initiatives, particularly in China, Japan, and India.

Conclusion

The global ventricular assist device market is poised for strong growth, expanding from USD 1.49 billion in 2025 to USD 4.25 billion by 2034. Rising heart failure prevalence, donor heart shortages, and rapid technological advancements in mechanical circulatory support systems are key factors driving market expansion. Although high implantation costs and device-related risks pose challenges, continuous innovation, expanding clinical applications, and improving healthcare infrastructure-especially in Asia Pacific-are expected to create significant long-term opportunities. Overall, the VAD market presents a highly promising outlook for manufacturers, healthcare providers, and investors throughout the forecast period.

Segmentation By Product

  • Left Ventricular Assist Device
  • Right Ventricular Assist Device
  • Bi-Ventricular Assist Device

By Type of Flow

  • Pulsatile Flow
  • Continuous Flow

By Application

  • Bridge to Transplant (BTT)
  • Bridge to Candidacy (BTC)
  • Destination Therapy (DT)
  • Bridge to Recovery (BTR)

By End-user

  • Hospitals & ASCs
  • Specialty Clinics & Others

By Geography

  • North America (By Product, By Type of Flow, By Application, and By Country)
    • U.S. (By Product)
    • Canada (By Product)
  • Europe (By Product, By Type of Flow, By Application, and By Country)
    • U.K. (By Product)
    • Germany (By Product)
    • France (By Product)
    • Italy (By Product)
    • Spain (By Product)
    • Rest of Europe (By Product)
  • Asia Pacific (By Product, By Type of Flow, By Application, and By Country)
    • China (By Product)
    • Japan (By Product)
    • India (By Product)
    • Australia (By Product)
    • Southeast Asia (By Product)
    • Rest of Asia Pacific (By Product)
  • Latin America (By Product, By Type of Flow, By Application, and By Country)
    • Brazil (By Product)
    • Mexico (By Product)
    • Rest of Latin America (By Product)
  • Middle East & Africa (By Product, By Type of Flow, By Application, and By Country)
    • GCC (By Product)
    • South Africa (By Product)
    • Rest of the Middle East & Africa (By Product)
Product Code: FBI106377

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Heart Failure, by Region, 2022/2025
  • 4.2. Number of Cardiac Surgeries, By Region/Country, 2022/2025
  • 4.3. New Product Launches, By Key Players
  • 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships; etc.)
  • 4.5. Impact of COVID-19 on the Market

5. Global Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Left Ventricular Assist Device
    • 5.1.2. Right Ventricular Assist Device
    • 5.1.3. Bi-Ventricular Assist Device
  • 5.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 5.2.1. Pulsatile Flow
    • 5.2.2. Continuous Flow
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Bridge to Transplant (BTT)
    • 5.3.2. Bridge to Candidacy (BTC)
    • 5.3.3. Destination Therapy (DT)
    • 5.3.4. Bridge to Recovery (BTR)
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospitals & ASCs
    • 5.4.2. Specialty Clinics & Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Left Ventricular Assist Device
    • 6.1.2. Right Ventricular Assist Device
    • 6.1.3. Bi-Ventricular Assist Device
  • 6.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 6.2.1. Pulsatile Flow
    • 6.2.2. Continuous Flow
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Bridge to Transplant (BTT)
    • 6.3.2. Bridge to Candidacy (BTC)
    • 6.3.3. Destination Therapy (DT)
    • 6.3.4. Bridge to Recovery (BTR)
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospitals & ASCs
    • 6.4.2. Specialty Clinics & Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
      • 6.5.1.1. By Product
    • 6.5.2. Canada
      • 6.5.2.1. By Product

7. Europe Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Left Ventricular Assist Device
    • 7.1.2. Right Ventricular Assist Device
    • 7.1.3. Bi-Ventricular Assist Device
  • 7.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 7.2.1. Pulsatile Flow
    • 7.2.2. Continuous Flow
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Bridge to Transplant (BTT)
    • 7.3.2. Bridge to Candidacy (BTC)
    • 7.3.3. Destination Therapy (DT)
    • 7.3.4. Bridge to Recovery (BTR)
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospitals & ASCs
    • 7.4.2. Specialty Clinics & Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-Region
    • 7.5.1. Germany
      • 7.5.1.1. By Product
    • 7.5.2. France
      • 7.5.2.1. By Product
    • 7.5.3. U.K.
      • 7.5.3.1. By Product
    • 7.5.4. Italy
      • 7.5.4.1. By Product
    • 7.5.5. Spain
      • 7.5.5.1. By Product
    • 7.5.6. Scandinavia
      • 7.5.6.1. By Product
    • 7.5.7. Rest of Europe
      • 7.5.7.1. By Product

8. Asia Pacific Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Left Ventricular Assist Device
    • 8.1.2. Right Ventricular Assist Device
    • 8.1.3. Bi-Ventricular Assist Device
  • 8.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 8.2.1. Pulsatile Flow
    • 8.2.2. Continuous Flow
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Bridge to Transplant (BTT)
    • 8.3.2. Bridge to Candidacy (BTC)
    • 8.3.3. Destination Therapy (DT)
    • 8.3.4. Bridge to Recovery (BTR)
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospitals & ASCs
    • 8.4.2. Specialty Clinics & Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-Region
    • 8.5.1. China
      • 8.5.1.1. By Product
    • 8.5.2. Japan
      • 8.5.2.1. By Product
    • 8.5.3. India
      • 8.5.3.1. By Product
    • 8.5.4. Australia
      • 8.5.4.1. By Product
    • 8.5.5. Southeast Asia
      • 8.5.5.1. By Product
    • 8.5.6. Rest of Asia Pacific
      • 8.5.6.1. By Product

9. Latin America Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Left Ventricular Assist Device
    • 9.1.2. Right Ventricular Assist Device
    • 9.1.3. Bi-Ventricular Assist Device
  • 9.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 9.2.1. Pulsatile Flow
    • 9.2.2. Continuous Flow
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Bridge to Transplant (BTT)
    • 9.3.2. Bridge to Candidacy (BTC)
    • 9.3.3. Destination Therapy (DT)
    • 9.3.4. Bridge to Recovery (BTR)
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospitals & ASCs
    • 9.4.2. Specialty Clinics & Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-Region
    • 9.5.1. Brazil
      • 9.5.1.1. By Product
    • 9.5.2. Mexico
      • 9.5.2.1. By Product
    • 9.5.3. Rest of the LATAM
      • 9.5.3.1. By Product

10. Middle East & Africa Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Left Ventricular Assist Device
    • 10.1.2. Right Ventricular Assist Device
    • 10.1.3. Bi-Ventricular Assist Device
  • 10.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 10.2.1. Pulsatile Flow
    • 10.2.2. Continuous Flow
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Bridge to Transplant (BTT)
    • 10.3.2. Bridge to Candidacy (BTC)
    • 10.3.3. Destination Therapy (DT)
    • 10.3.4. Bridge to Recovery (BTR)
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospitals & ASCs
    • 10.4.2. Specialty Clinics & Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-Region
    • 10.5.1. GCC
      • 10.5.1.1. By Product
    • 10.5.2. South Africa
      • 10.5.2.1. By Product
    • 10.5.3. Rest of Middle East & Africa
      • 10.5.3.1. By Product

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Berlin HeartOverview
      • 11.2.1.1. Products & Services
      • 11.2.1.2. SWOT Analysis
      • 11.2.1.3. Recent Developments
      • 11.2.1.4. Strategies
      • 11.2.1.5. Financials (Based on Availability)
    • 11.2.2. ABIOMED
      • 11.2.2.1. Products & Services
      • 11.2.2.2. SWOT Analysis
      • 11.2.2.3. Recent Developments
      • 11.2.2.4. Strategies
      • 11.2.2.5. Financials (Based on Availability)
    • 11.2.3. Abbott
      • 11.2.3.1. Products & Services
      • 11.2.3.2. SWOT Analysis
      • 11.2.3.3. Recent Developments
      • 11.2.3.4. Strategies
      • 11.2.3.5. Financials (Based on Availability)
    • 11.2.4. Jarvik Heart, Inc.
      • 11.2.4.1. Products & Services
      • 11.2.4.2. SWOT Analysis
      • 11.2.4.3. Recent Developments
      • 11.2.4.4. Strategies
      • 11.2.4.5. Financials (Based on Availability)
Product Code: FBI106377

List of Tables

  • Table 1: Global Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 2: Global Ventricular Assist Device Market Revenue (USD billion) Forecast, By Type of Flow, 2021-2034
  • Table 3: Global Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 4: Global Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 5: Global Ventricular Assist Device Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 7: North America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Type of Flow, 2021-2034
  • Table 8: North America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 9: North America Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 10: North America Ventricular Assist Device Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: U.S. Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 12: Canada Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 13: Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 14: Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, by Type of Flow, 2021-2034
  • Table 15: Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 16: Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 17: Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 18: Germany Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 19: U.K. Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 20: France Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 21: Italy Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 22: Spain Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 23: Scandinavia Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 24: Rest of Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 25: Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 26: Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, by Type of Flow, 2021-2034
  • Table 27: Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 28: Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 29: Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 30: Japan Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 31: India Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 32: China Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 33: Australia Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 34: Southeast Asia Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 35: Rest of Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 36: Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 37: Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Type of Flow, 2021-2034
  • Table 38: Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 39: Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 40: Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 41: Brazil Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 42: Mexico Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 43: Rest of Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 44: Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 45: Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by Type of Flow, 2021-2034
  • Table 46: Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 47: Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 48: Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 49: GCC Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 50: South Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 51: Rest of Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034

List of Figures

  • Figure 1: Global Ventricular Assist Device Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Ventricular Assist Device Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025 & 2034
  • Figure 4: Global Ventricular Assist Device Market Value Share (%), by Application, 2025 & 2034
  • Figure 5: Global Ventricular Assist Device Market Value Share (%), by End-user, 2025 & 2034
  • Figure 6: Global Ventricular Assist Device Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America Ventricular Assist Device Market Value (USD billion), by Product, 2025 & 2034
  • Figure 8: North America Ventricular Assist Device Market Value Share (%), by Product, 2025
  • Figure 9: North America Ventricular Assist Device Market Value (USD billion), By Type of Flow, 2025 & 2034
  • Figure 10: North America Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025
  • Figure 11: North America Ventricular Assist Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 12: North America Ventricular Assist Device Market Value Share (%), by Application, 2025
  • Figure 13: North America Ventricular Assist Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 14: North America Ventricular Assist Device Market Value Share (%), by End-user, 2025
  • Figure 15: North America Ventricular Assist Device Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Ventricular Assist Device Market Value Share (%), By Country, 2025
  • Figure 17: Europe Ventricular Assist Device Market Value (USD billion), by Product, 2025 & 2034
  • Figure 18: Europe Ventricular Assist Device Market Value Share (%), by Product, 2025
  • Figure 19: Europe Ventricular Assist Device Market Value (USD billion), By Type of Flow, 2025 & 2034
  • Figure 20: Europe Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025
  • Figure 21: Europe Ventricular Assist Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 22: Europe Ventricular Assist Device Market Value Share (%), by Application, 2025
  • Figure 23: Europe Ventricular Assist Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 24: Europe Ventricular Assist Device Market Value Share (%), by End-user, 2025
  • Figure 25: Europe Ventricular Assist Device Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Ventricular Assist Device Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Ventricular Assist Device Market Value (USD billion), by Product, 2025 & 2034
  • Figure 28: Asia Pacific Ventricular Assist Device Market Value Share (%), by Product, 2025
  • Figure 29: Asia Pacific Ventricular Assist Device Market Value (USD billion), By Type of Flow, 2025 & 2034
  • Figure 30: Asia Pacific Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025
  • Figure 31: Asia Pacific Ventricular Assist Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 32: Asia Pacific Ventricular Assist Device Market Value Share (%), by Application, 2025
  • Figure 33: Asia Pacific Ventricular Assist Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 34: Asia Pacific Ventricular Assist Device Market Value Share (%), by End-user, 2025
  • Figure 35: Asia Pacific Ventricular Assist Device Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Ventricular Assist Device Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Ventricular Assist Device Market Value (USD billion), by Product, 2025 & 2034
  • Figure 38: Latin America Ventricular Assist Device Market Value Share (%), by Product, 2025
  • Figure 39: Latin America Ventricular Assist Device Market Value (USD billion), By Type of Flow, 2025 & 2034
  • Figure 40: Latin America Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025
  • Figure 41: Latin America Ventricular Assist Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 42: Latin America Ventricular Assist Device Market Value Share (%), by Application, 2025
  • Figure 43: Latin America Ventricular Assist Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 44: Latin America Ventricular Assist Device Market Value Share (%), by End-user, 2025
  • Figure 45: Latin America Ventricular Assist Device Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Ventricular Assist Device Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Ventricular Assist Device Market Value (USD billion), by Product, 2025 & 2034
  • Figure 48: Middle East & Africa Ventricular Assist Device Market Value Share (%), by Product, 2025
  • Figure 49: Middle East & Africa Ventricular Assist Device Market Value (USD billion), By Type of Flow, 2025 & 2034
  • Figure 50: Middle East & Africa Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025
  • Figure 51: Middle East & Africa Ventricular Assist Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 52: Middle East & Africa Ventricular Assist Device Market Value Share (%), by Application, 2025
  • Figure 53: Middle East & Africa Ventricular Assist Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 54: Middle East & Africa Ventricular Assist Device Market Value Share (%), by End-user, 2025
  • Figure 55: Middle East & Africa Ventricular Assist Device Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Ventricular Assist Device Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Ventricular Assist Device Market Share (%), By Company, 2025
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!